Rapport Therapeutics RAPP
NASDAQ RAPP
$26.99 +1.93 (+7.72%)
As of: Oct 22, 2026 · 10:08 AM EDT

Rapport Therapeutics (RAPP) Ending Cash Balance (2023 - 2026)

Updated

Analysis

Rapport Therapeutics (RAPP) Ending Cash Balance (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn 20.42 Bn
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn 6.57 Bn
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn 4.88 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 1.03 Bn
10 Rapport Therapeutics 1.28 Bn 458.37 Mn - 63.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.72 Mn
Mar 31, 2026 78.16 Mn
Dec 31, 2025 52.75 Mn
Sep 30, 2025 251.46 Mn
Jun 30, 2025 55.17 Mn
Mar 31, 2025 57.71 Mn
Dec 31, 2024 56.91 Mn
Sep 30, 2024 39.42 Mn
Jun 30, 2024 110.27 Mn
Mar 31, 2024 74.37 Mn
Dec 31, 2023 70.25 Mn
Sep 30, 2023 159.41 Mn
Jun 30, 2023 79.53 Mn
API Access

Rapport Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RAPP&period=max&api_key=YOUR_API_KEY